Intraocular Lens

For cataract surgery, when we implant the IOL, the closer the optic is to the center of vision, the better it is for visual outcomes.

A new IOL from Alcon and a Q&A with Lisa M. Nijm, MD, JD, led Healio/OSN’s coverage in the first weeks of 2021.

IOLs must be centered precisely to achieve optimal refractive outcomes from advanced lens technology.

As I approach my eighth year straight of writing this monthly column, I still enjoy my year in review submission the most.

Alcon has launched the AcrySof IQ Vivity IOL, the first non-diffractive extended depth of focus IOL in the U.S.

The latest issue of Video Journal of Cataract, Refractive and Glaucoma Surgery, whose mission is to advance the knowledge and surgical training of eye surgeons through video-based education, is now online.

Increased odds of intraoperative complications in prescription opioid users and the merits of same-day bilateral cataract surgery led Healio/OSN’s 2020 cataract surgery coverage.

Positive 1-year results for a fluid-optic IOL and potential benefits of violet lights filters lead recent refractive surgery coverage.

In more than 99% of cataract surgery cases, the IOL that is implanted is left in position for life. However, there are rare cases in which we need to perform an IOL exchange, replacing the old IOL with a different IOL design or power.

Here are some of Healio/OSN’s top articles from the virtual American Academy of Ophthalmology annual meeting.